Publications by authors named "Irene StraSSl"

Claim this Profile
I
Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine.
Karin Deutsch-Biedermann, Katrin Hefler-Frischmuth, Judith Gruber, Christine Kimbacher, Isabella Herbring, Irene Strassl

Cytometry B Clin Cytom· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysis.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Ameya Kunte, Christina Groiss, Lorenz Mair, Irene Strassl

Cell Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
Alexander Nikoloudis, Anna Bauhofer, Lena Griessl, Anke Habermehl, Christina Groiss, Irene Strassl

Cytotherapy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia.
Christina Groiss, Stefanie Kreissl, Irene Strassl, Olga Saini, Dagmar Wipplinger

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.
Sigrid Machherndl-Spandl, Sarah Hannouf, Alexander Nikoloudis, Otto Zach, Irene Strassl

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber, Irene Strassl

Cytotherapy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The preclinical discovery and clinical development of ciltacabtagene autoleucel (Cilta-cel) for the treatment of multiple myeloma.
Irene Strassl, Klaus Podar

Expert Opin Drug Discov· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience.
Irene Strassl, Alexander Nikoloudis, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Michaela Binder

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center Analysis.
Alexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer-Ausch, Sigrid Machherndl-Spandl, Michaela Binder, Irene Strassl

Vaccines (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer.
Irene Strassl, Armin Windhager, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Olga Stiefel

J Cancer Res Clin Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the Recipient's Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation.
Alexander Nikoloudis, Veronika Buxhofer-Ausch, Christoph Aichinger, Michaela Binder, Petra Hasengruber, Irene Strassl

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attrition Rates in Multiple Myeloma Treatment under Real World Conditions-An Analysis from the Austrian Myeloma Registry (AMR).
Magdalena A Benda, Hanno Ulmer, Roman Weger, Patrick Reimann, Theresia Lang, Irene Strassl

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Agony of Choice-Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond.
Irene Strassl, Martin Schreder, Normann Steiner, Jakob Rudzki, Hermine Agis

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients.
Alexander Nikoloudis, Helga Wagner, Sigrid Machherndl-Spandl, Veronika Buxhofer-Ausch, Irene Strassl

Transplant Cell Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation.
Johannes Clausen, Alexandra Böhm, Irene Straßl, Olga Stiefel, Veronika Buxhofer-Ausch

Biomedicines· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis